Chicago and Seattle-based rMark Bio, a provider of AI solutions for life sciences companies, has raised $1.5 million in seed funding. Lincoln Park Capital led the round with participation from M25 Group, SaaS Ventures and MATH Venture Partners.
Source: Press Release
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: